Emilia Moonkyung Youm

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia

Hee-Jin Kim, Sun-Hee Kim, H. Won, 2018, Leukemia.

Abasic pivot substitution harnesses target specificity of RNA interference

S. Chi, H. Seok, Juyoung Ham, 2015, Nature Communications.

Novel Alzheimer’s disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers

D. Y. Lee, D. Na, S. Seo, 2021, Translational Psychiatry.